Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102070469A reveals chiral cyclic phosphoric acid resolution for high-purity metoprolol. Significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Grignard-based route for Apremilast intermediates ensures high purity and reduced waste, offering supply chain stability for pharmaceutical manufacturing partners.
Patent CN103228640B details enzymatic resolution for nebivolol. This reduces waste and avoids HPLC, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1738791A details a novel recovery method for chiral resolving agents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107151246A details chiral resolution for levo-praziquantel. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Novel ambrisentan synthetic method using LiOH base. Reduces cost and improves safety for pharmaceutical intermediates. Reliable supplier for commercial scale-up.
Patent CN111548383B details a scalable chemical resolution route for NMN, offering cost reduction in nutraceutical manufacturing and enhanced supply chain reliability.
Patent CN103980134A reveals high-purity S-metoprolol synthesis. Enhanced ee value and scalable process offer significant supply chain stability.
Novel four-step synthesis ensures high purity and scalable production for pharmaceutical supply chains reducing costs significantly and improving reliability for global buyers.
Advanced synthesis process for high-purity 6-bromo-1,2,3,4-tetrahydroisoquinoline. Reduces isomers, cuts solvent waste, and ensures reliable pharmaceutical intermediate supply.
Patent CN103626668B reveals a novel resolution method for S-Pregabalin offering high purity and scalable supply chain advantages for pharmaceutical manufacturers.
Novel resolution process for Finerenone ensures high optical purity and stable supply chain cost reduction in API intermediate manufacturing for global pharmaceutical partners seeking reliability.
Patent CN102020584A reveals a safer, cost-effective route for Levetiracetam intermediates using 2-bromobutyric acid, offering significant supply chain advantages.
Patent CN109790114B details high-purity Maraviroc intermediate synthesis using nickel chelates for improved yield and supply chain reliability in pharmaceutical manufacturing.
Patent CN109053526A details efficient synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.
Patent CN103044467A details a scalable route for R-(1-amino-3-methyl)butyl pinacol borate, eliminating cryogenic conditions and column chromatography for cost-effective manufacturing.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.
Novel water-based resolution method for R-tetrahydropapaverine ensures high purity and cost efficiency for cisatracurium besilate manufacturing.
Novel low-cost route for Sitagliptin intermediates via chiral resolution. Reduces catalyst costs and simplifies scale-up for API manufacturing.